Trials / Terminated
TerminatedNCT05801341
Inpatient COVID-19 Lollipop Study
The Utility of "Lollipop" Oral Swabs in the Diagnosis of COVID-19 in an Inpatient Setting
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to see if collecting saliva samples with a "lollipop" collection method works as well as nasopharyngeal samples for COVID-19 polymerase chain reaction (PCR) testing. 225 COVID-positive participants aged 4 years and above admitted to a hospital in the Madison, Wisconsin metropolitan area will be enrolled over a 6 month period.
Detailed description
This is a prospective quantitative study evaluating the utility of a novel method of saliva collection for COVID-19 testing. Primary Objective * To determine the performance characteristics of oral lollipop swabs compared to Nasal Pharyngeal (NP) swabs for diagnosing COVID-19 via PCR molecular testing. Secondary Objectives * To identify clinical characteristics of patients when there are discordant results for NP and oral lollipop test results.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lollipop | An oral lollipop swab will be obtained by placing a flocked swab into the mouth and sucking on the swab for 20 seconds as one would suck on a lollipop |
Timeline
- Start date
- 2023-04-20
- Primary completion
- 2023-05-24
- Completion
- 2023-05-24
- First posted
- 2023-04-06
- Last updated
- 2024-06-07
- Results posted
- 2024-05-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05801341. Inclusion in this directory is not an endorsement.